Teacher Retirement System of Texas reduced its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 47.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 62,871 shares of the company’s stock after selling 56,422 shares during the period. Teacher Retirement System of Texas’ holdings in Avanos Medical were worth $1,001,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in the business. William Blair Investment Management LLC lifted its position in shares of Avanos Medical by 2.1% during the 4th quarter. William Blair Investment Management LLC now owns 1,406,210 shares of the company’s stock valued at $22,387,000 after buying an additional 28,608 shares in the last quarter. Paradice Investment Management LLC lifted its holdings in Avanos Medical by 2.5% during the fourth quarter. Paradice Investment Management LLC now owns 1,293,198 shares of the company’s stock valued at $20,588,000 after purchasing an additional 30,949 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Avanos Medical by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company’s stock worth $25,337,000 after purchasing an additional 16,065 shares during the period. Tributary Capital Management LLC increased its stake in shares of Avanos Medical by 38.1% in the fourth quarter. Tributary Capital Management LLC now owns 893,008 shares of the company’s stock worth $14,217,000 after purchasing an additional 246,379 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of Avanos Medical by 3.5% during the 4th quarter. Principal Financial Group Inc. now owns 237,794 shares of the company’s stock valued at $3,786,000 after purchasing an additional 7,932 shares during the period. 95.17% of the stock is currently owned by institutional investors.
Avanos Medical Stock Performance
NYSE AVNS opened at $13.96 on Friday. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a twelve month low of $13.87 and a twelve month high of $25.36. The business has a 50-day moving average price of $15.66 and a 200-day moving average price of $18.34. The firm has a market cap of $641.97 million, a price-to-earnings ratio of 41.04 and a beta of 1.17.
Analyst Upgrades and Downgrades
Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a report on Wednesday, March 19th.
Check Out Our Latest Stock Analysis on AVNS
Insider Buying and Selling at Avanos Medical
In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the transaction, the senior vice president now owns 82,047 shares in the company, valued at $1,251,216.75. This trade represents a 7.86 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.64% of the stock is currently owned by insiders.
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Recommended Stories
- Five stocks we like better than Avanos Medical
- Trading Halts Explained
- MarketBeat Week in Review – 03/24 – 03/28
- Retail Stocks Investing, Explained
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is the Shanghai Stock Exchange Composite Index?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.